HF9C6

N/A

Report date: 2023/05/22 10:17:06
NME

Base Information

Drug NameHF9C6
Drug Alias NameHF-9-C-6
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCapsid protein modulators
TargetsCapsid protein
Therapy Area/IndicationsHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Missouri
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Missouri
Inactive CompaniesN/A
Active IndicationsHepatitis B
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A